Objectives: The long-term success of prosthetic vascular grafts for revascularization in peripheral arterial disease is limited by the development of anastomotic neointimal hyperplasia (ANIH). We have constructed a bioactive prosthetic graft material (BPGM) by coating polyethylene terephthalate with an antithrombogenic cryogel polymer layer capable of delivering biologic agents to human aortic endothelial cells in vitro. Our goal is to evaluate our hybrid prosthetic graft material in vivo using a rabbit carotid interposition bypass model. Methods: Our bioactive prosthetic graft material was synthesized by cryopolymerization of methacrylated alginate, methacrylated heparin, and ACRL-PEG-RGD, circumferentially coating 1.5 cm length by 2 mm diameter electrospun PET (ePET) grafts, and dipcoating in fluorescent small interfering RNA (siRNA) complexed with transfection reagent for 3 hours before implantation. A total of six rabbits were divided into two groups, with three rabbits receiving bare ePET dipcoated in fluorescent siRNA and three rabbits receiving cryogel-coated ePET graft material with fluorescent siRNA, to create an interposition bypass of the common carotid artery in an end-to-end fashion (Fig 1) . After 24 hours, rabbits were euthanized and bypass patency was assessed, with samples of the bypass taken at the proximal anastomosis, mid-graft, and distal anastomosis for frozen section to examine cell toxicity with hematoxylin and eosin staining. Confocal microscopy was used to visualize fluorescence, correlating with ability to deliver siRNA and transfect in vivo.
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Application of a Cryogel-Coated Prosthetic Vascular Graft Material for Delivery of Targeted Gene Therapies in a Rabbit Model
Objectives: The long-term success of prosthetic vascular grafts for revascularization in peripheral arterial disease is limited by the development of anastomotic neointimal hyperplasia (ANIH). We have constructed a bioactive prosthetic graft material (BPGM) by coating polyethylene terephthalate with an antithrombogenic cryogel polymer layer capable of delivering biologic agents to human aortic endothelial cells in vitro. Our goal is to evaluate our hybrid prosthetic graft material in vivo using a rabbit carotid interposition bypass model. Methods: Our bioactive prosthetic graft material was synthesized by cryopolymerization of methacrylated alginate, methacrylated heparin, and ACRL-PEG-RGD, circumferentially coating 1.5 cm length by 2 mm diameter electrospun PET (ePET) grafts, and dipcoating in fluorescent small interfering RNA (siRNA) complexed with transfection reagent for 3 hours before implantation. A total of six rabbits were divided into two groups, with three rabbits receiving bare ePET dipcoated in fluorescent siRNA and three rabbits receiving cryogel-coated ePET graft material with fluorescent siRNA, to create an interposition bypass of the common carotid artery in an end-to-end fashion (Fig 1) . After 24 hours, rabbits were euthanized and bypass patency was assessed, with samples of the bypass taken at the proximal anastomosis, mid-graft, and distal anastomosis for frozen section to examine cell toxicity with hematoxylin and eosin staining. Confocal microscopy was used to visualize fluorescence, correlating with ability to deliver siRNA and transfect in vivo.
Results: All rabbits underwent surgery without complications postoperatively. Patency of the prosthetic grafts was equal between the two groups, with hematoxylin and eosin staining showing no increased cell toxicity in samples collected from rabbits receiving the cryogel-coated prosthetic graft material. Confocal microscopy demonstrated no difference in retained fluorescence between rabbits receiving cryogel-coated ePET compared with bare ePET graft, and no increased transfection of cells at 24 hours (Fig 2) .
Conclusions: Creation of the optimal prosthetic vascular graft remains elusive and demands a material that is biocompatible, responsive, and nonthrombogenic. We have constructed a modified prosthetic graft material capable of in vitro delivery of targeted gene therapies to modulate the inflammatory response leading to the development of ANIH, with comparable patency and biocompatibility in our large animal model. Additional optimization of our BPGM to achieve predictable and sustained release is needed to validate this as an effective and practical method to deliver biologic agents in vivo from a prosthetic graft material.
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Metabolites Altered in Diabetic Macrophages Influence Chronic Inflammation
Methods: Diet-induced obese (DIO) mice were maintained on a 60% fat diet (HFD) for 12-18 weeks. Control mice were fed a 12% fat diet. Cross-section of the distal anastomosis in rabbits with bare electrospun PET (ePET) graft material compared with cryogel coated ePET. Confocal microscopy demonstrates no difference in retained fluorescence and no increased transfection of cells at 24 hours in cross-section of the distal anastomosis from rabbits receiving bare ePET graft material (left) and cryogel-coated ePET (right). With internal elastic lamina in green, fluorescent small interfering RNA in red and cell nuclei in blue.
